Cargando…
Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study
BACKGROUND: Many studies have predicted major depressive disorder (MDD) as the leading cause of global health by 2030 due to its high prevalence, disability, and illness. However, the actual pathophysiological mechanism behind depression is unknown. Scientists consider alterations in cytokines might...
Autores principales: | Rahman, Smaranika, Shanta, Amena Alam, Daria, Sohel, Nahar, Zabun, Shahriar, Mohammad, Qusar, MMA Shalahuddin, Islam, Sardar Mohammad Ashraful, Bhuiyan, Mohiuddin Ahmed, Islam, Md. Rabiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880862/ https://www.ncbi.nlm.nih.gov/pubmed/35213631 http://dx.doi.org/10.1371/journal.pone.0264404 |
Ejemplares similares
-
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
por: Akter, Sarmin, et al.
Publicado: (2023) -
Higher serum nerve growth factor levels are associated with major
depressive disorder pathophysiology: a case–control study
por: Salsabil, Lubaba, et al.
Publicado: (2023) -
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study
por: Sohan, Md., et al.
Publicado: (2023) -
Higher serum interleukin‐12 levels are associated with the pathophysiology of major depressive disorder: A case‐control study results
por: Nahar, Zabun, et al.
Publicado: (2022) -
Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study
por: Islam, Salsabil, et al.
Publicado: (2022)